ILDONG HOLDINGS CO.,LTD
000230 | KO
Overview
Corporate Details
- ISIN(s):
- KR7000230003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 바우뫼로27길 2 일동제약빌딩, 서울특별시
- Website:
- https://www.ildongholdings.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 129.0 KB | ||
| 2025-09-11 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 44.3 KB | ||
| 2025-08-26 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 128.8 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 2.1 MB | ||
| 2025-07-30 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.3 KB | ||
| 2025-07-30 00:00 |
M&A Activity
[기재정정]타법인주식및출자증권처분결정
|
Korean | 21.5 KB | ||
| 2025-07-30 00:00 |
Related Party Transaction
타법인주식및출자증권처분결정
|
Korean | 15.8 KB | ||
| 2025-07-28 00:00 |
Report Publication Announcement
결산실적공시예고(안내공시)
|
Korean | 4.1 KB | ||
| 2025-07-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 136.0 KB | ||
| 2025-07-08 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 50.2 KB | ||
| 2025-06-23 00:00 |
Related Party Transaction
타법인주식및출자증권처분결정
|
Korean | 17.1 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 1015.5 KB | ||
| 2025-05-27 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 128.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.9 MB | ||
| 2025-05-12 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.3 KB |
Automate Your Workflow. Get a real-time feed of all ILDONG HOLDINGS CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for ILDONG HOLDINGS CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ILDONG HOLDINGS CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing therapies for neurodegenerative diseases that cross the blood-brain barrier.
United States of America
DNLI
United States of America
DNLI
Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.
Germany
DMP
Germany
DMP
Develops OTC skin treatments using a unique delivery technology from freshwater sponges.
United States of America
DRMA
United States of America
DRMA
Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.
United States of America
DSGN
United States of America
DSGN
Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.
Germany
DBI
Germany
DBI
Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.
Spain
DEVA
Spain
DEVA
Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.
Sweden
DVYSR
Sweden
DVYSR
Developing pharmaceuticals for urological oncology using its proprietary GuaDex technology platform.
Sweden
DEX
Sweden
DEX
Developing a novel protein therapy for acute ischemic stroke and preeclampsia.
United States of America
DMAC
United States of America
DMAC
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
Developing precision immunotherapies to preserve insulin in autoimmune diabetes.
Sweden
DMYD
Sweden
DMYD